173 related articles for article (PubMed ID: 38097539)
21. Aberrant NSG1 Expression Promotes Esophageal Squamous Cell Carcinoma Cell EMT by the Activation of ERK Signaling Pathway.
Lin X; Tu M; Zhang Y; Zhuang W; Cai L; Zhang L; Yu L; Zhang Z; Huang Y
Dig Dis Sci; 2023 May; 68(5):1847-1857. PubMed ID: 36396779
[TBL] [Abstract][Full Text] [Related]
22. EPB41L5 promotes EMT through the ERK/p38 MAPK signaling pathway in esophageal squamous cell carcinoma.
Bao S; Ji Z; Shi M; Liu X
Pathol Res Pract; 2021 Dec; 228():153682. PubMed ID: 34784520
[TBL] [Abstract][Full Text] [Related]
23. Linkage between EMT and stemness state through molecular association between TWIST1 and NY-ESO1 in esophageal squamous cell carcinoma.
Ardalan Khales S; Abbaszadegan MR; Majd A; Forghanifard MM
Biochimie; 2019 Aug; 163():84-93. PubMed ID: 31158427
[TBL] [Abstract][Full Text] [Related]
24. DCLK1-Short Splice Variant Promotes Esophageal Squamous Cell Carcinoma Progression via the MAPK/ERK/MMP2 Pathway.
Ge Y; Fan X; Huang X; Weygant N; Xiao Z; Yan R; Liu H; Liu J; An G; Yao J
Mol Cancer Res; 2021 Dec; 19(12):1980-1991. PubMed ID: 34610960
[TBL] [Abstract][Full Text] [Related]
25. AKAP12 inhibits esophageal squamous carcinoma cell proliferation, migration, and cell cycle via the PI3K/AKT signaling pathway.
Li X; Dong H; Zheng Y; Ding S; Li Y; Li H; Huang H; Zhong C; Xie T; Xu Y
Mol Cell Probes; 2023 Dec; 72():101939. PubMed ID: 37879503
[TBL] [Abstract][Full Text] [Related]
26. TRAIL promotes epithelial-to-mesenchymal transition by inducing PD-L1 expression in esophageal squamous cell carcinomas.
Zhang H; Qin G; Zhang C; Yang H; Liu J; Hu H; Wu P; Liu S; Yang L; Chen X; Zhao X; Wang L; Zhang Y
J Exp Clin Cancer Res; 2021 Jun; 40(1):209. PubMed ID: 34167551
[TBL] [Abstract][Full Text] [Related]
27. miR-25 mediates metastasis and epithelial-mesenchymal-transition in human esophageal squamous cell carcinoma via regulation of E-cadherin signaling.
Liu B; Li X; Li C; Xu R; Sun X
Bioengineered; 2019 Dec; 10(1):679-688. PubMed ID: 31679450
[TBL] [Abstract][Full Text] [Related]
28. Glypican-1 Promotes Tumorigenesis by Regulating the PTEN/Akt/β-Catenin Signaling Pathway in Esophageal Squamous Cell Carcinoma.
Li J; Chen Y; Zhan C; Zhu J; Weng S; Dong L; Liu T; Shen X
Dig Dis Sci; 2019 Jun; 64(6):1493-1502. PubMed ID: 30730015
[TBL] [Abstract][Full Text] [Related]
29. Interaction with CCNH/CDK7 facilitates CtBP2 promoting esophageal squamous cell carcinoma (ESCC) metastasis via upregulating epithelial-mesenchymal transition (EMT) progression.
Zhang J; Zhu J; Yang L; Guan C; Ni R; Wang Y; Ji L; Tian Y
Tumour Biol; 2015 Sep; 36(9):6701-14. PubMed ID: 25820824
[TBL] [Abstract][Full Text] [Related]
30. MicroRNA-210 targets FBXO31 to inhibit tumor progression and regulates the Wnt/β-catenin signaling pathway and EMT in esophageal squamous cell carcinoma.
Meng J; Zhang C; Zhao T; Shi G; Zhao J; Lin Z
Thorac Cancer; 2021 Mar; 12(6):932-940. PubMed ID: 33538099
[TBL] [Abstract][Full Text] [Related]
31. Crosstalk between MMP-13, CD44, and TWIST1 and its role in regulation of EMT in patients with esophageal squamous cell carcinoma.
Mahmoudian RA; Gharaie ML; Abbaszadegan MR; Alasti A; Forghanifard MM; Mansouri A; Gholamin M
Mol Cell Biochem; 2021 Jun; 476(6):2465-2478. PubMed ID: 33604811
[TBL] [Abstract][Full Text] [Related]
32. PFN2, a novel marker of unfavorable prognosis, is a potential therapeutic target involved in esophageal squamous cell carcinoma.
Cui XB; Zhang SM; Xu YX; Dang HW; Liu CX; Wang LH; Yang L; Hu JM; Liang WH; Jiang JF; Li N; Li Y; Chen YZ; Li F
J Transl Med; 2016 May; 14(1):137. PubMed ID: 27188458
[TBL] [Abstract][Full Text] [Related]
33. Homeobox D10, a tumor suppressor, inhibits the proliferation and migration of esophageal squamous cell carcinoma.
Zhang J; Liu S; Zhang D; Ma Z; Sun L
J Cell Biochem; 2019 Aug; 120(8):13717-13725. PubMed ID: 30938888
[TBL] [Abstract][Full Text] [Related]
34. Keratin 17 activates AKT signalling and induces epithelial-mesenchymal transition in oesophageal squamous cell carcinoma.
Liu Z; Yu S; Ye S; Shen Z; Gao L; Han Z; Zhang P; Luo F; Chen S; Kang M
J Proteomics; 2020 Jan; 211():103557. PubMed ID: 31669361
[TBL] [Abstract][Full Text] [Related]
35. Akt-mediated transforming growth factor-β1-induced epithelial-mesenchymal transition in cultured human esophageal squamous cancer cells.
Xuan X; Zeng Q; Li Y; Gao Y; Wang F; Zhang H; Wang Z; He H; Li S
Cancer Gene Ther; 2014 Jun; 21(6):238-45. PubMed ID: 24874843
[TBL] [Abstract][Full Text] [Related]
36. Targeting the mitochondrial calcium uniporter inhibits cancer progression and alleviates cisplatin resistance in esophageal squamous cell carcinoma.
Miao Y; Wang X; Lai Y; Huang Y; Yin H; Meng X; Liu H; Hou R; Lin W; Zhang X; Zhang X; Chai BC; Zhang F; Guo L; Yang S
Int J Oncol; 2023 Jul; 63(1):. PubMed ID: 37264968
[TBL] [Abstract][Full Text] [Related]
37. Aberrant methylation-mediated silencing of lncRNA CTC-276P9.1 is associated with malignant progression of esophageal squamous cell carcinoma.
Guo W; Liu S; Dong Z; Guo Y; Ding C; Shen S; Liang J; Shan B
Clin Exp Metastasis; 2018 Feb; 35(1-2):53-68. PubMed ID: 29524086
[TBL] [Abstract][Full Text] [Related]
38. PURα mediates epithelial-mesenchymal transition to promote esophageal squamous cell carcinoma progression by regulating Snail2.
Gao J; Tian L; Sun Y; Li W; Zhao L; Sun Y; Jing Z; Zhou L; Liu F; Zhao X
Cancer Lett; 2021 Feb; 498():98-110. PubMed ID: 33144099
[TBL] [Abstract][Full Text] [Related]
39. MiR-99a suppresses proliferation, migration and invasion of esophageal squamous cell carcinoma cells through inhibiting the IGF1R signaling pathway.
Mei LL; Qiu YT; Huang MB; Wang WJ; Bai J; Shi ZZ
Cancer Biomark; 2017 Dec; 20(4):527-537. PubMed ID: 28800315
[TBL] [Abstract][Full Text] [Related]
40. Low mitochondrial DNA copy number induces chemotherapy resistance via epithelial-mesenchymal transition by DNA methylation in esophageal squamous cancer cells.
Kubo Y; Tanaka K; Masuike Y; Takahashi T; Yamashita K; Makino T; Saito T; Yamamoto K; Tsujimoto T; Harino T; Kurokawa Y; Yamasaki M; Nakajima K; Eguchi H; Doki Y
J Transl Med; 2022 Aug; 20(1):383. PubMed ID: 36038893
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]